经肛与腹腔镜全直肠系膜切除术治疗直肠癌的围手术期与肿瘤学结局比较:随机对照试验与前瞻性研究的Meta分析
该系统评价纳入截至2023年6月的22项研究共5056例患者(6项随机对照试验、16项前瞻性研究),比较经肛与腹腔镜全直肠系膜切除术的围手术期及肿瘤学结局。经肛组中转率显著低于腹腔镜组(OR 0.14,95%CI 0.09至0.22,P<0.01),环周切缘更长(MD 0.99 mm,95%CI 0.66至1.32 mm,P<0.01),环周切缘阳性率更低(OR 0.68,95%CI 0.47至0.97,P=0.03);其余指标无统计学显著差异。
要点
- 经肛组中转率显著低于腹腔镜组(OR 0.14,95%CI 0.09至0.22,P<0.01)。
- 经肛组环周切缘更长(MD 0.99 mm,95%CI 0.66至1.32 mm,P<0.01)且环周切缘阳性率更低(OR 0.68,95%CI 0.47至0.97,P=0.03)。
- 手术时间、术中出血、并发症、吻合口漏、直肠系膜切除质量、淋巴结检出数、远端切缘、局部复发及远处复发等均无统计学显著差异(P>0.05)。
核心结论
- 基于随机对照试验与前瞻性研究的Meta分析结果,经肛全直肠系膜切除术在转流率(中转率)和环周切缘受累方面似乎优于腹腔镜全直肠系膜切除术。
研究设计与样本
- 系统检索PubMed、Embase和Cochrane Library数据库,检索截止至2023年6月。
- 采用Cochrane质量评估工具和纽卡斯尔-渥太华量表评估研究质量。
- 共纳入22项研究、5056例患者,其中6项为随机对照试验、16项为前瞻性研究。
- 使用I2统计量评估统计异质性,并进行敏感性分析。
主要发现
- 经肛组中转率显著低于腹腔镜组(OR 0.14,95%CI 0.09至0.22,P<0.01)。
- 经肛组环周切缘长度长于腹腔镜组(MD 0.99 mm,95%CI 0.66至1.32 mm,P<0.01)。
- 经肛组环周切缘阳性率低于腹腔镜组(OR 0.68,95%CI 0.47至0.97,P=0.03)。
- 手术时间、术中出血量、并发症、吻合口漏、尿潴留、肠梗阻、二次手术、住院时间、尿道损伤、再入院、30天内死亡率、直肠系膜切除质量、淋巴结检出数、远端切缘、远端切缘阳性、局部复发及远处复发均无统计学显著差异(P>0.05)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Meta-analysis of the results of transanal total mesorectal excision (taTME) and laparoscopic TME (laTME) regarding perioperative and oncological outcomes have been conducted. Due to the lack of high-quality randomized controlled trials (RCTs) and prospective studies in the included literature, the conclusions are unreliable. This study included RCTs and prospective studies for analysis to obtain more reliable conclusions. MATERIALS AND METHODS: Systematic searches of the PubMed, Embase, and Cochrane Library databases were conducted up to June 2023. To assess the quality, the Cochrane quality assessment tool and the Newcastle-Ottawa Scale were employed. The perioperative and oncological outcomes were then analyzed. The I2 statistic was used to evaluate statistical heterogeneity and sensitivity analyses was conducted. RESULTS: A total of 22 studies, comprising 5056 patients, were included in the analysis, of which 6 were RCTs and 16 were prospective studies. The conversion rate in the taTME group was significantly lower than that in the laTME group (OR 0.14, 95% CI 0.09 to 0.22, P < 0.01), and the circumferential resection margin (CRM) was longer (MD 0.99 mm, 95% CI 0.66 to 1.32 mm, P < 0.01), with a lower rate of positive CRM involvement (OR 0.68, 95% CI 0.47 to 0.97, P = 0.03). No statistically significant differences were found in terms of the operation time, intraoperative blood loss, complications, anastomotic leakage, uroschesis, obstruction, secondary operation, hospital stay, urethral injury, readmission, mortality rate within 30 days, mesorectal resection quality, number of harvested lymph nodes, distal resection margin (DRM), positive DRM, local recurrence, and distance recurrence (P > 0.05). CONCLUSION: According to the findings of this meta-analysis, which is based on RCTs and prospective studies, taTME appears to have an advantage over laTME in terms of conversion rate and CRM involvement.
引用
- Yi X, Zhang X, Li Q, et al. Comparing perioperative and oncological outcomes of transanal and laparoscopic total mesorectal excision for rectal cancer: a meta-analysis of randomized controlled trials and prospective studies. Surg Endosc. 2023. PMID: 37872424. doi:10.1007/s00464-023-10495-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。